Ocugen, Inc.
OCGN
$2.59
$0.2610.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.83% | 14.26% | -34.54% | -31.56% | -32.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.83% | 14.26% | -34.54% | -31.56% | -32.82% |
| Cost of Revenue | 20.44% | 13.45% | 5.84% | -12.60% | -34.94% |
| Gross Profit | -22.60% | -13.26% | -23.19% | 7.21% | 35.33% |
| SG&A Expenses | 3.35% | 8.75% | -8.88% | -11.16% | -16.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 646.75% | 116,700.00% | -- | -- | -- |
| Total Operating Expenses | 16.22% | 16.02% | 1.87% | -7.40% | -18.04% |
| Operating Income | -16.77% | -16.18% | -7.00% | 4.73% | 16.68% |
| Income Before Tax | -25.52% | -25.18% | -14.13% | 0.34% | 14.31% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.52% | -25.18% | -14.13% | 0.34% | 14.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.52% | -25.18% | -14.13% | 0.34% | 14.31% |
| EBIT | -16.77% | -16.18% | -7.00% | 4.73% | 16.68% |
| EBITDA | -14.70% | -13.07% | -3.32% | 8.16% | 18.81% |
| EPS Basic | -12.96% | -11.24% | -1.75% | 10.93% | 23.70% |
| Normalized Basic EPS | -13.04% | -11.32% | -1.81% | 10.98% | 23.69% |
| EPS Diluted | -12.96% | -11.24% | -1.75% | 10.93% | 24.62% |
| Normalized Diluted EPS | -13.04% | -11.32% | -1.81% | 10.98% | 23.69% |
| Average Basic Shares Outstanding | 10.77% | 12.35% | 12.21% | 10.88% | 10.92% |
| Average Diluted Shares Outstanding | 10.77% | 12.35% | 12.21% | 10.88% | 10.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |